Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

M. Kitahata, Mari; J. Gange, Stephen; G. Abraham, Alison; Merriman, Barry; S Saag, Michael; C. Justice, Amy; S. Hogg, Robert; G. Deeks, Steven; J. Eron, Joseph; T. Brooks, John; B. Rourke, Sean; John Gill, M.; J. Bosch, Ronald; N. Martin, Jeffrey; B. Klein, Marina; P. Jacobson, Lisa; Rodríguez, Benigno; R. Sterling, Timothy; D. Kirk, Gregory; Napravnik, Sonia; Rachlis, Anita; Calzavara, Liviana; A. Horberg, Michael; J. Silverberg, Michael; A. Gebo, Kelly; J. Goedert, James; A. Benson, Constance; C. Collier, Ann; E. Van Rompaey, Stephen; M. Crane, Heidi; G. McKaig, Rosemary; Lau, Bryan; Freeman, Aimee; D. Moore, Richard

doi:10.1056/nejmoa0807252

Public

Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

Published in New England Journal of Medicine • Apr 1, 2009

Authors:

Mari M. Kitahata

Stephen J. Gange

Alison G. Abraham

Abstract

BACKGROUND: The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain. METHODS: We conducted two parallel analyses involving a total of 17,517 asymptomatic patients with HIV infection in the United States an...

Subject

Medicine

Antiretroviral therapy

Asymptomatic

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!